Viral MHC class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming |
| |
Authors: | Maria D. Gainey Joshua G. Rivenbark Hyelim Cho Liping Yang Wayne M. Yokoyama |
| |
Affiliation: | aRheumatology Division, Department of Medicine.;bDepartment of Molecular Microbiology, and;cHoward Hughes Medical Institute, Washington University School of Medicine in St. Louis, St. Louis, MO, 63110 |
| |
Abstract: | ![]() Although viral MHC class I inhibition is considered a classic immune-evasion strategy, its in vivo role is largely unclear. Mutant cowpox virus lacking its MHC class I inhibitors is markedly attenuated during acute infection because of CD8+ T-cell–dependent control, but it was not known how CD8+ T-cell responses are affected. Interestingly, we found no major effect of MHC class I down-regulation on priming of functional cowpox virus-specific CD8+ T cells. Instead, we demonstrate that, during acute infection in vivo, MHC class I down-regulation prevents primed virus-specific CD8+ T cells from recognizing infected cells and exerting effector responses to control the infection. |
| |
Keywords: | immune response orthopoxvirus virus evasion |
|
|